DRYVAX
DryVax is a technology that allows the manufacture of vaccines that have aluminum-containing adjuvants into a dosage form that is not sensitive to freezing, intentionally or unintentionally. This technology can have a profound impact on the existing vaccine supply-chain because cold-chain storage accounts for up to 80% of the financial cost of vaccination, and an estimated 75-100% of the vaccine shipments are exposed to freezing temperatures resulting in costly waste and the loss of nearly half of all global vaccine supplies. This technology will also open markets that lack cold-chain storage and as a result were unreachable for broad vaccine distribution.
DRYVAX
Industry:
Information Technology Manufacturing Medical
Address:
Austin, Texas, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Zephyr Technology
Zephyr Technology is a manufacturer of heart rate monitors, remote physiological monitoring and wireless tele-health systems.
Investors List
Texas Venture Labs
Texas Venture Labs investment in Non Equity Assistance - Dryvax